Compounded GLP-1 Without Insurance: Cash-Pay and Self-Pay
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency.
If you have looked into semaglutide or tirzepatide and hit a wall with your insurance, you are not alone. Many plans exclude weight-management medications outright, and the ones that cover them often require prior authorization, step therapy, and weeks of back-and-forth. Insurance is not the only route. This page explains how cash-pay compounded programs work, what a monthly fee may or may not cover, and how they compare with manufacturer self-pay and savings options.
Transformation Health is an independent guide, not a provider: we do not prescribe, compound, or sell medication. This content is for general education and is not medical advice. Talk with a licensed provider about your situation.
You do not need insurance to start
Many telehealth programs that prescribe compounded semaglutide or tirzepatide are cash-pay. You pay the program directly, and no insurance plan is involved. That means:
- No prior authorization. You are not waiting on an insurer to approve the prescription.
- No coverage denial. A plan that excludes weight-management medication does not decide whether you can use a cash-pay program.
- No claims or paperwork. There is nothing to file and no reimbursement to chase.
Paying cash does not skip the clinical step. At most telehealth programs, a licensed provider reviews your health history and decides whether a prescription is appropriate. And cash-pay compounded programs are not the only option without insurance: both manufacturers of brand-name semaglutide and tirzepatide list self-pay options, covered below.
What the monthly price covers
There is no standard bundle. Prices vary by program and dose, and what a monthly fee includes varies too. Transformation Health does not sell medication or set prices. We plan to publish current market prices with sources and capture dates; until then, check each of these line items and note whether it is included, billed separately, or not offered:
- The medication. Compounded medication is prepared by a state-licensed compounding pharmacy. Ask which pharmacy prepares it and whether the price changes as the dose increases.
- Lab work. Some programs require blood work before or during treatment. Ask whether it is included and where it is drawn.
- Provider care. Ask whether the intake review and ongoing follow-up visits are included or billed per visit.
- Coaching or nutrition support. Some programs include it; many do not.
- Shipping and supplies. Check whether shipping, syringes, alcohol pads, and sharps containers are included.
- Membership fees and cancellation terms. Look for separate membership or consultation fees, minimum commitments, prepay requirements, and how cancellation works.
Compare the total cost: medication at your likely dose, dose increases, visits, labs, shipping, membership fees, and cancellation terms. For a deeper look at what drives the price, see the compounded semaglutide cost guide.
Transformation Health does not accept payment from providers. How we make money.
How cash-pay compares to using insurance
For weight-management medication, paying out of pocket is sometimes the simpler path, and sometimes not the cheapest one.
If your plan covers it. A covered brand-name GLP-1 can cost you less than any cash-pay option, but prior authorization can delay a prescription for weeks or months, and step-therapy rules may require you to try other approaches first. If your plan recently turned you down, our guide on what to do when insurance denies your GLP-1 walks through appeals and other routes.
Manufacturer self-pay and savings programs. Novo Nordisk fills Wegovy self-pay prescriptions through NovoCare Pharmacy, and the price varies by dose[1]. Eli Lilly lists a Zepbound KwikPen self-pay offer for patients without insurance, on Medicare, or with government coverage, through LillyDirect Pharmacy or another pharmacy[2]. Manufacturer savings cards are a separate route: as of 2026-10-16, both generally require commercial insurance and exclude government coverage[1][2]. Terms change, so check each manufacturer’s current page. More detail is in our guide to GLP-1 savings programs.
Cash-pay compounded programs. Compounded medication generally costs less than brand-name medication paid out of pocket. That difference reflects a different production and regulatory model, not clinical equivalence. Compounded semaglutide and tirzepatide are not FDA-approved and are not the same products as Wegovy or Zepbound.
Regulatory status. FDA determined the tirzepatide injection shortage was resolved (reissued December 19, 2024) and the semaglutide injection shortage was resolved on February 21, 2025. After court rulings on March 5, 2025 (tirzepatide) and April 24, 2025 (semaglutide), FDA stated that its enforcement discretion period for state-licensed 503A pharmacies had ended; for 503B outsourcing facilities it ran until March 19, 2025 for tirzepatide and May 22, 2025 for semaglutide[3]. The FDA page has later updates, most recently dated April 1, 2026; check it for the current statement[3]. Compounded versions are still offered by some programs, but availability depends on federal and state law and FDA action and can change.
Who qualifies
Paying cash does not change the clinical bar. A licensed provider decides whether a GLP-1 medication is appropriate based on your health history, and programs set their own criteria.
Your BMI. Many programs use criteria similar to those in the brand-name trials. The SURMOUNT-1 trial of tirzepatide, for example, enrolled adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, abnormal cholesterol, obstructive sleep apnea, or heart disease[4].
Your health history. The provider reviews your current medications, existing conditions, and any contraindications to GLP-1 therapy. Some health histories make a GLP-1 medication a poor fit even when the BMI threshold is met.
The provider’s judgment. Meeting the numbers does not guarantee a prescription. The decision rests with the provider, not with you and not with Transformation Health.
If you want to see what providers look for before you start, our GLP-1 eligibility guide covers it in detail.
State requirements
Where you live can change how the process starts. Some states require a live video visit before certain prescriptions can be written; a program should tell you if that applies where you live. Elsewhere, many programs start with an online health-history form. Either way, the clinical decision is made by a licensed provider.
We're relaunching soon
We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.
Get StartedImportant disclosures
This content is for general education and is not medical advice. Talk with a licensed provider about your situation.
Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed[5]. They are not the same as brand-name products such as Wegovy or Zepbound, which went through FDA review, and they may differ in formulation, purity, and potency. You cannot assume the compounded and brand-name versions will produce the same results.
Regulatory status is subject to change. Compounding of semaglutide and tirzepatide depends on federal and state pharmacy law and on FDA policy, which has changed since FDA determined both shortages were resolved[3]. Availability cannot be guaranteed.
Results vary, and weight loss is not guaranteed. How much weight you lose depends on many factors, including your starting weight, age, metabolism, adherence, eating habits, activity, sleep, and overall health. Trial results describe study participants and are not a prediction for any individual.
Citations
[1] Novo Nordisk. “Save on Wegovy” (coverage and savings). Accessed 2026-10-16. https://www.wegovy.com/coverage-and-savings/save-on-wegovy.html
[2] Eli Lilly and Company. “Zepbound Coverage and Savings.” Accessed 2026-10-16. https://zepbound.lilly.com/coverage-savings
[3] U.S. Food and Drug Administration. “FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.” Content current as of 04/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize (Accessed 2026-10-16.)
[4] Jastreboff AM, Aronne LJ, Ahmad NN, et al. “Tirzepatide once weekly for the treatment of obesity.” NEJM. 2022. https://pubmed.ncbi.nlm.nih.gov/35658024/
[5] U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of 10/01/2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss (Accessed 2026-10-16.)
Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, or sell medication. A licensed provider decides whether a prescription is appropriate. Compounded semaglutide and tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency. Results vary. Trial results describe study participants and are not a prediction for any individual. Availability of compounded GLP-1 medications depends on FDA policy and applicable state and federal pharmacy compounding laws, which may change. Manufacturer self-pay and savings program terms change; check the manufacturer's website for current terms. Wegovy is a trademark of Novo Nordisk A/S. Zepbound is a trademark of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies. Transformation Health does not accept payment from providers. How we make money.